National Heart, Lung, and Blood Institute

New Capabilities

Funded PROSpect

For more than 30 years, pediatric intensive care doctors have argued over whether turning a desperately ill child face-down, or ventilating them with hundreds of tiny rapid breaths per minute, helps more than standard care. A 424-patient international trial published in The Lancet found neither did.

Updated 3 hours ago

New Capabilities

Funded the CLOVERS trial

Septic shock treatment rests on a simple rule: give fluids fast and plenty of them. A trial in the New England Journal of Medicine tested the opposite strategy — less fluid, earlier vasopressors — and found patients did just as well.

Updated Oct 17

Money Moves

As of September 2026: Funded ELPIS II through NIH grants; collaborated with Longeveron

Longeveron's stem cell therapy for a rare pediatric heart disease missed the main goal of its mid-stage trial, and the Miami biotech is now fighting to stay alive. With about $10.1 million in cash at the end of June, the company announced a strategic review and cost-cutting plan.

Updated Sep 17